FIELD: medicine. SUBSTANCE: method involves evaluating patient state using 17-leveled scale of depression after Hamilton before applying treatment. The initial number dropping by more than 40% at the 28-35 treatment day in patients of asthenic and normosthenic somatic type and at the 14-21 day in patients of hypersthenic somatic type, positive treatment dynamics is to be predicted. EFFECT: high reliability of prognosis. 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING NEGATIVE CLINICAL MANIFESTATIONS IN SCHIZOPHRENIA FLOW | 2001 |
|
RU2188577C1 |
| METHOD FOR PREDICTING RECURRENT RISK IN CLINICAL COURSE OF DEPRESSIVE DISORDERS AFTER CARRYING OUT ANTIDEPRESSANT THERAPY | 2004 |
|
RU2266048C2 |
| METHOD OF CORRECTION OF PSYCHOPATHIC BEHAVIOR OF PERSONS SHOWING SCHIZOID PSYCHOPATHY | 1993 |
|
RU2094046C1 |
| ANTIDEPRESSIVE THERAPY | 2008 |
|
RU2379035C1 |
| METHOD FOR TREATING PATIENTS WITH EXOGENIC-ORGANIC BRAIN LESION | 2001 |
|
RU2194489C1 |
| METHOD FOR PREDICTING THE FLOW OF DEPRESSIVE REACTIONS | 2003 |
|
RU2239190C1 |
| METHOD FOR REVEALING CLINICAL SPECIFIC OF BOUNDARY NEUROPSYCHIC DISORDERS | 2000 |
|
RU2168312C1 |
| METHOD OF OPHTHALMOHERPES TREATMENT ASSOCIATED WITH PROLONGED DEPRESSIONS | 2006 |
|
RU2327449C1 |
| METHOD FOR PREDICTING CLINICAL BEHAVIOR OF CARDIAC ISCHEMIA DISEASE | 2001 |
|
RU2228534C2 |
| METHOD OF TREATING THERAPEUTICALLY RESISTANT PATIENTS WITH SCHIZOPHRENIA | 1999 |
|
RU2177326C2 |
